Sellas Life Sciences Group Inc is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer

The company is dedicated to advancing its therapeutic candidates through clinical trials, aiming to address unmet medical needs in oncology. By leveraging proprietary technology and scientific expertise, Sellas seeks to provide patients with effective treatment options that harness the body’s immune system to target and combat cancerous cells. Their pipeline includes various late-stage candidates designed to offer new hope for better outcomes in cancer care.